ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch
By filer · By stock

$LQDA:NASDAQ · LIQUIDIA CORPORATION

Sector: health

Conviction from: NASDAQ

52-week range: 21.1493.61

Inhaled-therapy biopharma (pulmonary hypertension)

2 tracked filer(s) hold this · 1 opened, 0 added, 1 trimmed in 30-JUN-2026

Aggregate 13FScore 70 — mean of 2 scored holder(s) · buyers (new/add) avg 76. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Steve Cohen / Point7276New buy2,800$223,2440.0%
Paul Tudor Jones / Tudor63Trimmed -65%16,400$1,307,5720.0%

Beyond 13F — activists, insiders, politicians & research

Insider open-market buys daily digest →

FiledInsiderRoleSharesValue
2026-05-20Caligan Partners LPdirector+10%-owner5,300$317,894Form 4

Trump & executive branch trades all Trump/exec trades →

3 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-09-22Trump, Donald J PresidentSELL$50,001 - $100,000PTR
2026-09-22Trump, Donald J PresidentSELL$1,001 - $15,000PTR
2026-08-22Trump, Donald J PresidentBUY$50,001 - $100,000PTR

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.